Furiex Pharmaceuticals (FURX)

Add to Watchlists
Create an Alert
78.71 +1.22  +1.57% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD
View Full Chart
FURX Price Chart
View All Events

FURX Events

Date Type Description
May 08 Misc Q1 2014 Furiex Pharmaceuticals Earnings Conference Call
May 07 Earnings Q1 2014 Furiex Pharmaceuticals Earnings Results. Estimate: -0.39.
Mar 12 Misc Furiex Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Mar 11 Earnings Furiex Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -1.05.
Nov 06 Misc Furiex Pharmaceuticals Announces Third Quarter 2013 Earnings Release and Conference Call
Nov 05 Earnings Furiex Pharmaceuticals Announces Third Quarter 2013 Earnings Release. Estimate: -1.82.
Aug 07 Misc Furiex Pharmaceuticals Announces Second Quarter 2013 Earnings Release and Conference Call
Aug 06 Earnings Furiex Pharmaceuticals Announces Second Quarter 2013 Earnings Release and Conference Call. Estimate: -0.28.
May 08 Misc Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference Call
May 07 Earnings Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release. Estimate: 1.56.
View All Performance Charts

FURX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Furiex Pharmaceuticals is up 137.9% over the last year vs S&P 500 Total Return up 18.46%, DepoMed up 134.1%, and Lannett Company up 216.4%.

Get Quote for

Pro Report PDF for FURX

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download FURX Pro Report PDF
Advertisement

Pro Strategies Featuring FURX

Did Furiex Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

FURX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Furiex Pharmaceuticals, Inc. is a drug development collaborate company that collaborates with pharmaceutical and biotechnology companies to increase the value of their drug candidates by applying an accelerated approach to drug development.

Recent Quotes

Symbol Price Chg Chg % Market Cap
FURX 78.71 +1.22 +1.57% 835.09M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.